Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
BRAF mutation
Description:
A genetic alteration in the BRAF gene, studied for its role in cancer biology, diagnosis, and treatment.
Related topics:
Colorectal Cancer Treatments and Studies (18%),
Melanoma and MAPK Pathways (16%),
Thyroid Cancer Diagnosis and Treatment (11%),
Genetic factors in colorectal cancer (7%)
Wikidata ID:
wiki/Q28445087
OpenAlex ID:
keywords/braf-mutation
Mutations of the BRAF gene in human cancer
2002
·
Helen Davies
, Graham R. Bignell
, et al.
·
Nature
·
10,871
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017
·
Jedd D. Wolchok
, Vanna Chiarion-Sileni
, et al.
·
New England Journal of Medicine
·
5,508
PDF
Genomic Classification of Cutaneous Melanoma
2015
·
Rehan Akbani
, Kadir C. Akdemir
, et al.
·
Cell
·
3,324
PDF
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014
·
Nishant Agrawal
, Rehan Akbani
, et al.
·
Cell
·
3,222
PDF
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
2014
·
Wei Li
, Han Xu
, et al.
·
Genome biology
·
2,843
PDF
Distinct Sets of Genetic Alterations in Melanoma
2005
·
John A. Curtin
, Jane Fridlyand
, et al.
·
New England Journal of Medicine
·
2,811
PDF
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006
·
James A. McCubrey
, Linda S. Steelman
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
2,373
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
2013
·
Jean-Yves Douillard
, Kelly S. Oliner
, et al.
·
New England Journal of Medicine
·
2,330
PDF
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
2006
·
Astrid Lièvre
, Jean-Baptiste Bachet
, et al.
·
Cancer Research
·
2,274
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
2010
·
Wendy De Roock
, Bart Claes
, et al.
·
The Lancet Oncology
·
2,206
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
2006
·
Daniel J Weisenberger
, Kimberly D Siegmund
, et al.
·
Nature Genetics
·
2,052
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005
·
Andrea H. Bild
, Guang Yao
, et al.
·
Nature
·
2,025
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
2011
·
Eric Van Cutsem
, Claus-Henning Köhne
, et al.
·
Journal of Clinical Oncology
·
1,932
High frequency of BRAF mutations in nevi
2002
·
Pamela M. Pollock
, Ursula L. Harper
, et al.
·
Nature Genetics
·
1,787
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
2014
·
Marcia S Brose
, Christopher M Nutting
, et al.
·
The Lancet
·
1,736
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
2007
·
Nicholas Yagoda
, Moritz von Rechenberg
, et al.
·
Nature
·
1,680
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
2013
·
Laetitia Marisa
, Aurélien de Reyniès
, et al.
·
PLoS Medicine
·
1,600
PDF
Initial genome sequencing and analysis of multiple myeloma
2011
·
Michael A. Chapman
, Michael S. Lawrence
, et al.
·
Nature
·
1,474
PDF
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
2006
·
J R Jass
·
Histopathology
·
1,423
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
2016
·
Iñigo Landa
, Tihana Ibrahimpasic
, et al.
·
Journal of Clinical Investigation
·
1,352
PDF
BRAF mutation predicts sensitivity to MEK inhibition
2005
·
David B. Solit
, Levi A. Garraway
, et al.
·
Nature
·
1,339
BRAF mutation in thyroid cancer
2005
·
M Xing
·
Endocrine Related Cancer
·
1,318
PDF
Immune checkpoint inhibitors in melanoma
2021
·
Matteo S Carlino
, James Larkin
, et al.
·
The Lancet
·
1,305
RAF/RAS oncogenes and mismatch-repair status
2002
·
Harith Rajagopalan
, Alberto Bardelli
, et al.
·
Nature
·
1,258
Ovarian Tumorigenesis
2004
·
Ie-Ming Shih
, Robert J. Kurman
·
American Journal Of Pathology
·
1,227
PDF
Show more works
View as search
Works count:
14,810
Citation count:
425,400
Year
Topic
Type